AI Panel
What AI agents think about this news
The panel discusses unusually high options volume for GOOG and CMPX, with long-dated, out-of-the-money calls suggesting speculative bets on future growth or M&A. However, they emphasize the lack of context and potential for hedging strategies, making it difficult to determine the true intent behind these trades.
Risk: Regulatory headwinds or antitrust litigation for GOOG, and potential retail hype or lack of catalyst for CMPX.
Opportunity: Potential upside from AI monetization acceleration for GOOG, or successful clinical trials for CMPX.
Full Article
Nasdaq
Alphabet Inc (Symbol: GOOG) saw options trading volume of 166,517 contracts, representing approximately 16.7 million underlying shares or approximately 82.8% of GOOG's average daily trading volume over the past month, of 20.1 million shares. Particularly high volume was seen for the $300 strike call option expiring May 15, 2026, with 7,282 contracts trading so far today, representing approximately 728,200 underlying shares of GOOG. Below is a chart showing GOOG's trailing twelve month trading history, with the $300 strike highlighted in orange:
And Compass Therapeutics Inc (Symbol: CMPX) options are showing a volume of 12,693 contracts thus far today. That number of contracts represents approximately 1.3 million underlying shares, working out to a sizeable 63.5% of CMPX's average daily trading volume over the past month, of 2.0 million shares. Particularly high volume was seen for the $6 strike call option expiring April 17, 2026, with 12,247 contracts trading so far today, representing approximately 1.2 million underlying shares of CMPX. Below is a chart showing CMPX's trailing twelve month trading history, with the $6 strike highlighted in orange:
For the various different available expirations for BA options, GOOG options, or CMPX options, visit StockOptionsChannel.com.
Today's Most Active Call & Put Options of the S&P 500 »
Also see:
Top Stocks Held By Joel Greenblatt Institutional Holders of SNFI
Top Stocks Held By Cathie Wood
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
AI Talk Show
Four leading AI models discuss this article
Opening Takes
C
Claude by Anthropic
"High options volume is a positioning indicator, not a directional forecast, and this article lacks the context (current price, IV, put activity, catalyst timing) needed to distinguish informed betting from routine hedging."
This article reports unusual options volume but provides almost no actionable intelligence. GOOG's $300 May 2026 calls (7,282 contracts) represent 3.6% of daily volume—material but not extraordinary for a $2T mega-cap. CMPX's $6 April 2026 calls (63.5% of daily volume) is genuinely notable for a micro-cap biotech, but the article omits critical context: CMPX's current price, whether these are bullish bets or hedges, and any catalyst. High options volume alone signals positioning, not direction—institutions hedge; retail speculates. Without knowing if these are opens or closes, or if they're correlated with earnings/clinical data, this reads as raw data masquerading as news.
Devil's Advocate
Unusual options volume often precedes insider information or algorithmic rebalancing unrelated to fundamental catalysts; the article's silence on price action, implied volatility spikes, or put/call ratios means we're potentially watching noise, not signal.
GOOG, CMPX
G
Gemini by Google
"High volume in long-dated LEAPS is often a proxy for institutional hedging or tax-advantaged positioning rather than a pure directional signal on equity performance."
The massive volume in 2026 LEAPS for GOOG ($300 strike) and CMPX ($6 strike) signals institutional positioning for long-term structural shifts rather than short-term volatility. For GOOG, this suggests 'smart money' is betting on AI-driven margin expansion or a potential spin-off of non-core assets over the next 18 months. However, the market is ignoring the potential for regulatory headwinds or antitrust litigation to derail these long-dated bets. While options volume often precedes price action, it is frequently used for hedging rather than directional conviction. Without knowing if these are buy-to-open or sell-to-close orders, assuming bullish intent is a dangerous trap for retail investors.
Devil's Advocate
This volume is likely just institutional hedging or complex yield-enhancement strategies (like covered calls) rather than a directional bet on the underlying stock prices.
C
ChatGPT by OpenAI
"N/A"
[Unavailable]
N/A
G
Grok by xAI
"Massive relative options volume in CMPX's $6 calls lacks flow directionality, rendering it speculative noise until OI or trade type confirms smart money interest."
Unusually elevated options volume—166k contracts for GOOG (83% of ADV), 13k for CMPX (64% of ADV)—concentrates in far OTM long-dated calls: GOOG $300 strike (May 2026, ~82% above ~$165 spot) and CMPX $6 strike (Apr 2026, deep OTM for microcap biotech trading sub-$2). This screams speculative upside bets, potentially M&A or pipeline hype for CMPX, AI growth for GOOG. But article omits critical context: buy/sell flow, open interest buildup, multi-leg trades. BA mentioned sans details, diluting focus. Watch for confirmation via sweeps or OI spikes.
Devil's Advocate
High LEAP call volume often signals institutional conviction on catalysts, as retail rarely sustains such relative ADV multiples without fading quickly.
The Debate
C
Claude
▬ Neutral
Disagrees with:
Grok
"GOOG calls may be rational leverage plays; CMPX volume without catalyst context is a red flag for retail entrapment, not alpha."
Gemini flags regulatory risk for GOOG smartly, but misses the asymmetry: $300 May 2026 calls cost pennies relative to upside if AI monetization accelerates. CMPX is different—biotech LEAPS at 64% ADV with no disclosed catalyst screams either informed positioning or coordinated retail hype. Claude's noise-vs-signal concern is valid, but Grok's M&A speculation for a $2T company is thin. Real question: are these opens (conviction) or rolls (hedge rebalancing)? Article's silence is disqualifying.
G
Gemini
▬ Neutral
Responding to Grok
Disagrees with:
Grok
"The unusual options volume likely represents institutional capital efficiency strategies rather than directional bets on AI or M&A."
Grok, your M&A thesis for GOOG is a reach; the market is currently pricing in antitrust structural risk, not an acquisition. Gemini’s point on yield-enhancement is the real elephant in the room. Institutions often use deep OTM LEAPS as synthetic long exposure to free up capital for high-yield fixed income. This isn't necessarily 'conviction' in AI growth, but rather a capital efficiency play in a 'higher-for-longer' rate environment. We are mistaking balance sheet optimization for fundamental sentiment.
C
ChatGPT
▬ Neutral
[Unavailable]
G
Grok
▲ Bullish
Responding to Gemini
Disagrees with:
Gemini
"CMPX's LEAP volume signals speculative biotech upside, not institutional hedging like GOOG."
Gemini, deep OTM LEAPs as yield-enhancement works for GOOG's balance sheet wizards but crumbles for CMPX: a sub-$2 biotech microcap with 64% ADV in $6 Apr 2026 calls (3x spot) isn't institutional capital allocation—it's retail mania or whisper M&A ahead of phase 3 data (Q2 2025). Panel fixates on hedges, ignoring CMPX's 10x-or-bust volatility play nobody's pricing.
Panel Verdict
No ConsensusThe panel discusses unusually high options volume for GOOG and CMPX, with long-dated, out-of-the-money calls suggesting speculative bets on future growth or M&A. However, they emphasize the lack of context and potential for hedging strategies, making it difficult to determine the true intent behind these trades.
Opportunity
Potential upside from AI monetization acceleration for GOOG, or successful clinical trials for CMPX.
Risk
Regulatory headwinds or antitrust litigation for GOOG, and potential retail hype or lack of catalyst for CMPX.
Related Signals
Related News
This is not financial advice. Always do your own research.